Pharming Group NV (PHAR): Price and Financial Metrics
PHAR Price/Volume Stats
| Current price | $9.10 | 52-week high | $13.20 |
| Prev. close | $8.94 | 52-week low | $6.65 |
| Day low | $9.05 | Volume | 3,800 |
| Day high | $9.27 | Avg. volume | 5,239 |
| 50-day MA | $8.32 | Dividend yield | N/A |
| 200-day MA | $8.77 | Market Cap | 617.30M |
PHAR Stock Price Chart Interactive Chart >
Pharming Group NV (PHAR) Company Bio
Pharming Group NV is a biopharmaceutical company involved with the development, production and commercialization of human therapeutic proteins to be used in highly innovative therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage, and surgical/traumatic bleeding.
PHAR Price Returns
| 1-mo | 17.27% |
| 3-mo | 19.97% |
| 6-mo | 10.04% |
| 1-year | -21.48% |
| 3-year | 1.34% |
| 5-year | N/A |
| YTD | -20.38% |
| 2023 | 3.63% |
| 2022 | 23.38% |
| 2021 | -41.16% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...